Navelbine and respiratory failure Patient Reports February 11, 2012

Navelbine Side Effects Report #4952698-7
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Apr 12, 2005. Male patient, 64 years of age, was diagnosed with pleural mesothelioma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, lung disorder, pneumonia , pneumonia viral, respiratory failure. Navelbine dosage: unknown. During the same period patient was treated with GEMZAR, PARAPLATIN, DECADRON SRC, PREDONINE, CRAVIT, OMEGACIN. Patient died on 04/02/2004.

Navelbine Side Effects Report #5926755-2
Navelbine side effect was reported by a Consumer or non-health professional from FRANCE on Oct 06, 2008. Male patient, 61 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Navelbine. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, leukopenia, lung disorder, pyrexia, respiratory failure. Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died.

Navelbine Side Effects Report #5956028-3
Navelbine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 31, 2008. Female patient, 48 years of age, was diagnosed with non-small cell lung cancer stage iiia and was treated with Navelbine. After drug was administered, patient experienced the following side effects: collapse of lung, diarrhoea, hypotension, lung consolidation, neutropenic sepsis, pleural effusion, renal failure, respiratory failure. Navelbine dosage: 60 MG/M2 PO. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 06/19/2008.

Navelbine Side Effects Report #5632976-9
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Jan 25, 2008. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Navelbine dosage: unknown. During the same period patient was treated with TAKEPRON. Patient died on 01/11/2008.


Navelbine Side Effects Report #5647232-2
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 08, 2008. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: interstitial lung disease, neutrophil count increased, respiratory failure, white blood cell count increased. Navelbine dosage: 30 MG QD IV. During the same period patient was treated with TAKEPRON. Patient died on 01/11/2008.

Navelbine Side Effects Report #5472281-7
Navelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: performance status decreased, respiratory failure. Navelbine dosage: 25 MG/M2 IV. Patient died.

Navelbine Side Effects Report #5472282-9
Navelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: performance status decreased, respiratory failure. Navelbine dosage: 25 MG/M2 IV. Patient died.

Navelbine Side Effects Report #4763692-3
Navelbine side effect was reported by a Physician from GERMANY on Sept 06, 2005. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anxiety , cardiovascular disorder, multi-organ failure, pneumonia , pyothorax, respiratory failure, shock. Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN, PACLITAXEL, FENISTIL. Patient was hospitalized. Patient died on 08/01/2005.

Navelbine Side Effects Report #4788617-6
Navelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2005. Female patient, 54 years of age, weighting 218.5 lb, was diagnosed with non-small cell lung cancer, hypertension, asthma , depression  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, neoplasm malignant, pneumonitis, respiratory failure, thrombosis. Navelbine dosage: unknown. During the same period patient was treated with GEMZAR, EUTHYROX, ACECOMB, ACEMIN, NORVASC, BERODUAL, FLUCTINE, PARACODIN BITARTRATE. Patient was hospitalized. Patient died on 10/11/2003.


Navelbine Side Effects Report #4828168-3
Navelbine side effect was reported by a Consumer or non-health professional from AUSTRIA on Sept 29, 2005. Female patient, 54 years of age, weighting 218.5 lb, was diagnosed with non-small cell lung cancer, hypertension, asthma , depression  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: arterial occlusive disease, haemoptysis, neoplasm malignant, pain in extremity, pneumonitis, rectal haemorrhage, respiratory failure, thrombosis. Navelbine dosage: unknown. During the same period patient was treated with GEMZAR, EUTHYROX, ACECOMB, ACEMIN, NORVASC, BERODUAL, FLUCTINE, PARACODIN BITARTRATE. Patient was hospitalized. Patient died on 10/11/2003.

Navelbine Side Effects Report #4995868-4
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Apr 04, 2006. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: pulmonary embolism , respiratory failure. Navelbine dosage: unknown. During the same period patient was treated with PYDOXAL, TENORMIN, NORVASC, MECOBALAMIN. Patient recovered.

Navelbine Side Effects Report #5026733-4
Navelbine side effect was reported by a Health Professional from JAPAN on May 17, 2006. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: activities of daily living impaired, intracardiac thrombus, neuropathy peripheral, pulmonary embolism , respiratory failure. Navelbine dosage: unknown. During the same period patient was treated with PYDOXAL, TENORMIN, NORVASC, MECOBALAMIN, CODEINE PHOSPHATE, ZANTAC. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4954478-5
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Mar 03, 2006. Female patient, 53 years of age, was diagnosed with inflammatory carcinoma of the breast and was treated with Navelbine. After drug was administered, patient experienced the following side effects: interstitial lung disease, metastases to lung, pneumocystis jiroveci pneumonia, respiratory failure. Navelbine dosage: unknown. Patient died on 02/17/2006.

Navelbine Side Effects Report #4713305-1
Navelbine side effect was reported by a Health Professional from SPAIN on July 07, 2005. Female patient, 59 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonia , respiratory failure. Navelbine dosage: unknown. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, OMEPRAZOLE, METOCLOPRAMIDE, ONDANSETRON. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #5528990-4
Navelbine side effect was reported by a Consumer or non-health professional from SWITZERLAND on Oct 29, 2007. Male patient, 58 years of age, was treated with Navelbine. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood ph decreased, lung injury, pseudomonas infection, respiratory failure, septic shock. Navelbine dosage: unknown. During the same period patient was treated with MITOMYCIN, CISPLATIN. Patient died.